Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disorder of motor neurons which leads to complete loss of movement in patients. The only FDA approved drug Riluzole provides only symptomatic relief to patients. Early Diagnosis of the disease warrants the importance of diagnostic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosla, Radhika, Rain, Manjari, Sharma, Suresh, Anand, Akshay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894922/
https://www.ncbi.nlm.nih.gov/pubmed/33606761
http://dx.doi.org/10.1371/journal.pone.0247025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894922/
https://www.ncbi.nlm.nih.gov/pubmed/33606761
http://dx.doi.org/10.1371/journal.pone.0247025

Ejemplares similares